Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 20 of 32

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Evaluation of Hypotony and Other Complications of the 25–Gauge Sutureless Vitrectomy System

V.L. Morrison; I. Falkenstein; A.M. Tammewar; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4659.

ARVO Annual Meeting Abstract May 2006

Synthesis and Investigation of Hexadecyloxypropyl 5–Fluoro–2–Deoxyuridine Cyclic 3,5–Monophosphate for Antiproliferation in Vitreoretinal Diseases

L. Cheng; N. Valiaeva; A.M. Tammewar; K. Hostetler; I. Falkenstein; J. Beadle; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5121.

ARVO Annual Meeting Abstract May 2006

Effect of Glitazone Therapy for Diabetes on Macular Thickness and Vision: Preliminary Safety Study

D.–U.G. Bartsch; I. Kozak; I. Falkenstein; A. Tammewar; R.R. Henry; P. Burke; L. Cheng; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5437.

ARVO Annual Meeting Abstract May 2006

An Immunohistochemical (IHC) Examination of Tumor Necrosis Factor (TNF–) Presence in the Optic Nerves of Patients With Chronic HIV Infection

A.M. Hayden; F.N. Ross–Cisneros; D.T. Nguyen; W.R. Freeman; A.A. Sadun

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1085.

ARVO Annual Meeting Abstract May 2006

Co–Localization Studies of Cotton Wool Spot Damage Using a Novel Combined Scanning Laser Ophthalmoscope (SLO)/Optical Coherence Tomography (OCT) Device

I. Kozak; D.–U. Bartsch; V.L. Morrison; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2641.

ARVO Annual Meeting Abstract May 2006

An Emerging Problem: Recurrence of CNV in AMD is Common After Cessation of 24 Month Treatment With Ranibizumab (Lucentis®)

A. Korotkin; I. Kozak; V.L. Morrison; L. Magana; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):2961.

ARVO Annual Meeting Abstract May 2006

Intraocular Properties of Urokinase–Derived Antiangiogenic Å36 Peptide in Rabbits

I. Falkenstein; L. Cheng; T.R. Jones; G. Lam; I. Kozak; A.M. Tammewar; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3884.

ARVO Annual Meeting Abstract May 2006

Intraocular Properties in Rabbit Eyes of Hexadecyloxypropyl–Cyclic–HPMPA, a Potent Crystalline Anti CMV Lipid Prodrug of HPMPA

A.M. Tammewar; L. Cheng; K.Y. Hostetler; I. Falkenstein; J.R. Beadle; I. Kozak; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3885.

ARVO Annual Meeting Abstract May 2005

Comparison of Scanning Laser Polarimetry and Optical Coherence Tomography Optic Nerve Head Analysis in HIV Patients Without Infectious Retinitis

D.–U.G. Bartsch; I. Kozak; L. Cheng; O. Kayikcioglu; A. McCutchan; R.N. Weinreb; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):265.

ARVO Annual Meeting Abstract May 2005

A Novel Intravitreally Injectable, Crystalline Prodrug of 5–Fluorouracil (HDP–P–5f2'du) for Sustained Intraocular Drug Delivery to Treat Pathologic Intraocular Proliferation

Y.K. Wu; L. Cheng; K.Y. Hostetler; O. Kayikcioglu; N. Valiaeva; J. Beadle; G. Bergeron–Lynn; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):471.

ARVO Annual Meeting Abstract May 2005

Recombinant Human Hyaluronidase Facilitates Dexamethasone Penetration Into the Posterior Ocular Segment After Xub–Tenon's Injection

I. Kozak; O.R. Kayikcioglu; L. Cheng; G.I. Frost; M.F. Haller; J.E. Lim; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):478.

ARVO Annual Meeting Abstract May 2005

High Dose Intravitreal Kenalog for the Treatment of Immune Recovery Uveitis Macular Edema

V.L. Morrison; I. Kozak; O.R. Kayikcioglu; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1015.

ARVO Annual Meeting Abstract May 2005

Subretinal Administration of Ribozyme to the Proliferating Cell Nuclear Antigen and 5–fluorouracil in Rat Eyes

O.R. Kayikcioglu; L. Cheng; I. Kozak; G. Bergeron–Lynn; C.T. Schulteis; F.W. Staal; N. Paoni; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1427.

ARVO Annual Meeting Abstract May 2005

Risk of Immune Recovery Uveitis in Patients With Cytomegalovirus Retinitis and the Acquired Immune Deficiency Syndrome

J.H. Kempen; Y.I. Min; W.R. Freeman; G.N. Holland; D.N. Friedberg; D.T. Dieterich; D.A. Jabs; Studies of Ocular Complications of AIDS Research Group

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3479.

ARVO Annual Meeting Abstract May 2005

Intraocular Properties of Silicon Photonic Crystals for Intravitreal Drug Delivery and Sensing

L.–Y. Cheng; M.J. Sailor; O. Kayikcioglu; D. Kim; I. Kozak; G. Bergeron–Lynn; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3537.

ARVO Annual Meeting Abstract May 2005

Verteporfin Enhanced Feeder Vessel Therapy for Choroidal Neovascularization

W.R. Freeman; I. Kozak

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3570.

ARVO Annual Meeting Abstract May 2004

An Efficient Gene Transferring Vector For Retinal Pigment Epithelium Cells

L.–Y. Cheng; M. Toyoguchi; D.J. Looney; J. Lee; H.J. Koh; M.C. Davidson; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3704.

ARVO Annual Meeting Abstract May 2004

Intraocular properties of 1–O–hexadecyloxypropyl–cyclic–cidofovir in guinea pigs

S.Y. Lu; L. Cheng; K.Y. Hostetler; H.J. Koh; J.R. Beadle; M.C. Davidson; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):4554.

ARVO Annual Meeting Abstract May 2004

Intraocular Properties of Urokinase–derived Anti–angiogenic Å6 Peptide in Rabbits

H.J. Koh; L. Cheng; K. Bessho; T.R. Jones; M.C. Davidson; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):5231.

ARVO Annual Meeting Abstract May 2004

Objective analysis of vision loss in HIV–positive patients in the HAART era using OCT.

I. Kozak; D.–U. Bartsch; B. Kosobucki; L. Cheng; W.R. Freeman

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1131.

1 2

Next 20 Results »

Advertisement